Cargando…

Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation

Adult neurogenesis is impaired by inflammatory processes, which are linked to altered cholinergic signalling and cognitive decline in Alzheimer's disease. In this study, we investigated how amyloid beta (Aβ)-evoked inflammatory responses affect the generation of new neurons from human embryonic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malmsten, Linn, Vijayaraghavan, Swetha, Hovatta, Outi, Marutle, Amelia, Darreh-Shori, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196662/ https://www.ncbi.nlm.nih.gov/pubmed/25109373 http://dx.doi.org/10.1111/jcmm.12343

Ejemplares similares

β-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons
por: Wicklund, Linn, et al.
Publicado: (2010)

Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons
por: Nilbratt, Mats, et al.
Publicado: (2010)

Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs
por: Kumar, Rajnish, et al.
Publicado: (2016)

Soluble Aβ42 Acts as Allosteric Activator of the Core Cholinergic Enzyme Choline Acetyltransferase
por: Kumar, Amit, et al.
Publicado: (2018)

CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment
por: Karami, Azadeh, et al.
Publicado: (2021)

Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway
por: Vijayaraghavan, Swetha, et al.
Publicado: (2013)

Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs
por: Lilja, Anna M., et al.
Publicado: (2015)

Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers
por: Mitra, Sumonto, et al.
Publicado: (2021)

CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease
por: Karami, Azadeh, et al.
Publicado: (2019)

Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas
por: Sinclair, Lindsey Isla, et al.
Publicado: (2019)

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
por: Kadir, Ahmadul, et al.
Publicado: (2011)

(3)H-Deprenyl and (3)H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain
por: Marutle, Amelia, et al.
Publicado: (2013)

Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects
por: Teitsdottir, Unnur D., et al.
Publicado: (2022)

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization
por: Kumar, Rajnish, et al.
Publicado: (2016)

Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer’s Disease Brain
por: Darreh-Shori, Taher, et al.
Publicado: (2018)

Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1
por: Brahic, Michel, et al.
Publicado: (2016)

Fast Alpha Activity in EEG of Patients With Alzheimer’s Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor
por: Eyjolfsdottir, Helga, et al.
Publicado: (2022)

Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
por: Kumar, Rajnish, et al.
Publicado: (2017)

Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis
por: Aeinehband, Shahin, et al.
Publicado: (2015)

C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta
por: Hernandez, Michael X., et al.
Publicado: (2017)

Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
por: Teitsdottir, Unnur D., et al.
Publicado: (2020)

Allosteric Binding Sites of Aβ Peptides on the Acetylcholine Synthesizing Enzyme ChAT as Deduced by In Silico Molecular Modeling
por: Baidya, Anurag TK, et al.
Publicado: (2022)

Is there a sodium effect in fibrillar amyloid-β oligomers?
por: Horn, Anselm HC, et al.
Publicado: (2014)

Fibrillar Amyloid Plaque Formation Precedes Microglial Activation
por: Jung, Christian K. E., et al.
Publicado: (2015)

Conservation of the Amyloid Interactome Across Diverse Fibrillar Structures
por: Juhl, Dennis Wilkens, et al.
Publicado: (2019)

Biomarkers in Alzheimer's Disease and Lewy Body Disorders with Dementia
por: Leyhe, Thomas, et al.
Publicado: (2013)

Cholinergic neurons—keeping check on amyloid β in the cerebral cortex
por: Ovsepian, Saak V., et al.
Publicado: (2013)

Stability of single and double layer fibrillar amyloid-β oligomers
por: Kahler, Anna, et al.
Publicado: (2013)

Amyloid-β Pathology-Specific Cytokine Secretion Suppresses Neuronal Mitochondrial Metabolism
por: Kuhn, Madison K., et al.
Publicado: (2023)

Polymorphism of fibrillar structures depending on the size of assembled Aβ(17-42) peptides
por: Cheon, Mookyung, et al.
Publicado: (2016)

The Effect of Ultrasonication on the Fibrillar/ Oligomeric Structures of Aβ(1−42) at Different Concentrations
por: Faridi, Nassim, et al.
Publicado: (2023)

Impact of α-Synuclein Fibrillar Strains and β-Amyloid Assemblies on Mouse Cortical Neurons Endo-Lysosomal Logistics
por: Chou, Qiao-Ling, et al.
Publicado: (2022)

A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
por: Nordberg, Agneta, et al.
Publicado: (2012)

Infrared nanospectroscopy characterization of oligomeric and fibrillar aggregates during amyloid formation
por: Ruggeri, F. S., et al.
Publicado: (2015)

Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer’s Disease Status and Risk Genotype
por: Lana, Erica, et al.
Publicado: (2019)

Rationally Designed Bicyclic Peptides Prevent the Conversion of Aβ42 Assemblies Into Fibrillar Structures
por: Ikenoue, Tatsuya, et al.
Publicado: (2021)

Oligomeric and Fibrillar Species of Aβ42 Diversely Affect Human Neural Stem Cells
por: Bernabeu-Zornoza, Adela, et al.
Publicado: (2021)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
por: Pan, Xiao-dong, et al.
Publicado: (2011)

Amyloid Beta Peptide (Aβ(1-42)) Reverses the Cholinergic Control of Monocytic IL-1β Release
por: Richter, Katrin, et al.
Publicado: (2020)

Editorial: Brain cholinergic mechanisms
por: Vijayaraghavan, Sukumar, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mung5a9spvet97frd7rb86m2ar